Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Squamous Cell Carcinoma Article
This is a selection made from among articles on Drug Treatment Squamous Cell Carcinoma. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Testing Methods at Work Place.
from: A drug test is commonly a technical examination to determine the presence or absence of specified drugs or their metabolized traces. According to the Chicago land Chamber of Commerce, Over 70% of all illicit drug users are employed. Small and medium-sized firms employ 80% of the U.S. workforce where drug testing policies & programs are not in place. Absenteeism, increased health care costs and decreased productivity due to alcohol and other substance abuse cost a company $1,000 per employee per year. It gives the importance of drug testing at work place.Primarily there are five methods of drug testing. Those are
. Urine drug testing: Urine drug test is the most common, inexpensive, simple and easy to administer. Urine drug tests are reliable and can be tested individually and at other places.
. Blood drug testing: Blood testing is one of the most accurate drug testing but intrusive and expensive.
. Hair drug testing: When used in right time hair testing gives more accurate results and it is most expensive drug testing.
. Saliva drug testing: Oral drug testing is the simplest form of drug testing, which is increasingly used, as it is the least intrusive test procedure.
. Sweat drug testing: Sweat tests are patches attached to the skin to collect sweat over a long period of time (1014 days).
Drug testing, and particularly random drug testing is not allowed in every state in the United States. There are certain guidelines mentioned by The Federal Drug-Free Work Place Act of 1988. Following guidelines give the minimum requirements.
. Publish a policy statement prohibiting unlawful use, possession, manufacture, or distribution of controlled substances in the workplace;
. Notify employees of said prohibition and the penalty for violating it;
. Establish a drug-free awareness program;
. Provide employees engaged in a contract with a copy of the policy statement;
. Notify employees that compliance with the policy statement is a condition of employment;
. Require (in writing in your policy) employees to notify the employer within five
. Days if they are convicted of a criminal drug statute violation occurring in the workplace;
. Make a good-faith effort to maintain a drug-free workplace through these provisions.
In 2004 SAMHSA proposed a new rule that would allow federal agencies to use sweat, saliva and hair in federal drug testing programs that now only test urine. The proposal would also allow selected specimen testing at the time and place it is collected.
Drug testing has an important role in safety-critical and other occupations where the public is entitled to expect the highest standards of safety and probity. In order to make the workforce free from drug use at work places several new methods are in line under the rules proposed by SAMHSA that are unintrusive, inescapable and yield accurate results.
About Author
DrugAlcoholTest.com is an online store offering drug testing and drug screening products in several formats including blood, urine and oral drug test kits. Some of the popular products are marijuana drug test, breathalyzer and saliva drug test products. A professionally management company that is a responsible, and socially aware company with a mission to make ours a healthier and better society.
Source: ArticleTrader.com
Drug Treatment Squamous Cell Carcinoma Specific links
Drug Treatment Squamous Cell Carcinoma News
RPT-Glaxo melanoma drug combo shows promise in small trial - Reuters
 Updated News | RPT-Glaxo melanoma drug combo shows promise in small trial Reuters * Progression-free survival of 7.4 months * Much lower incidence of squamous cell cancer By Deena Beasley May 16 (Reuters) - Two drugs being developed by GlaxoSmithKline Plc - each designed to block different pathways used by cancer cells - have been ... Glaxo melanoma drug combo shows promise in small trial Glaxo's Melanoma Cocktail Slows Cancer in Study GSK lands one-two punch in melanoma trial |
Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell ... - MarketWatch (press release)
Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell ... MarketWatch (press release) It is characterized by several types of lung cancers, each of which grow and spread in different ways, including: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. About Nexavar (sorafenib)Nexavar is approved in the US for the ... |
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps ... - Newswise (press release)
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps ... Newswise (press release) While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas β the most common type of non-small cell lung cancer β and have developed drugs that can successfully address them, scientists have not yet identified ... |
Testing for mutations identified in squamous cell lung cancer tumors helps ... - Medical Xpress
Testing for mutations identified in squamous cell lung cancer tumors helps ... Medical Xpress While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas β the most common type of non-small cell lung cancer β and have developed drugs that can successfully address them, scientists have not yet identified ... |
Glaxo's Melanoma Cocktail Slows Cancer in Study - Bloomberg
 TopNews Arab Emirates | Glaxo's Melanoma Cocktail Slows Cancer in Study Bloomberg GlaxoSmithKline Plc (GSK)'s combination of two experimental melanoma medicines slowed the progress of cancer with few skin complications in an early study, suggesting the combo may not have as many side effects as existing single- drug treatments. Dabrafenib And Trametinib: Melanoma Drug Combo Shows Promise In Small Trial Dabrafenib Safe in Melanoma With Brain Mets ASCO: Dabrafenib/Trametinib active in metastatic melanoma |
Melanoma Monday: Everything you need to know about skin cancer - Fox News
Melanoma Monday: Everything you need to know about skin cancer Fox News Types of skin cancer There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma and melanoma. Basal and squamous cell skin cancers (considered non-melanomas) start at the base of the skin's outer layer (the epidermis) in ... |
Cannabis Science Receives New Photos and Information on Patient Three's ... - MarketWatch (press release)
Cannabis Science Receives New Photos and Information on Patient Three's ... MarketWatch (press release) Cannabis Science continues to work closely with its third patient, who is self-treating his otherwise resistant Squamous Cell Carcinoma. The patient has seen dramatic improvements. He has been applying a topical cannabis extract to his cancer, ... |
Screening finds skin cancer: Does it save lives? - msnbc.com
Screening finds skin cancer: Does it save lives? msnbc.com There were also 1961 basal cell carcinomas, 392 squamous cell carcinomas and 165 were other types of malignant tumors. Did the screening help? The United States' National Cancer Institute says about two million people in the US are treated for basal ... |
Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO - Science Codex
Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO Science Codex Of the 280 patients, 106 were treated with induction chemotherapy followed by chemoradiotherapy, and 174 were treated with chemoradiotherapy alone. Patients with HPV-positive oropharyngeal squamous cell cancer treated with chemoradiotherapy alone had ... |
Late Stage Cancer Treatment Trends, Multiple Myeloma Vaccine, Predictors of ... - PR Web (press release)
Late Stage Cancer Treatment Trends, Multiple Myeloma Vaccine, Predictors of ... PR Web (press release) Of the 280 patients, 106 were treated with induction chemotherapy followed by chemoradiotherapy, and 174 were treated with chemoradiotherapy alone. Patients with HPV-positive oropharyngeal squamous cell cancer treated with chemoradiotherapy alone had ... |